Bijal D. Shah, MD

Where You Are:

Bijal D. Shah, MD

Medical Oncology

For Consultation Requests or Referrals: (888) 860-2778

 
 

BOARD CERTIFICATION:
          •  Pediatrics
          •  Internal Medicine - Medical Oncology
          •  Internal Medicine - Hematology

FELLOWSHIP:
          •  Moffitt Cancer Center - Hematology & Oncology

RESIDENCY:
          •  Duke University - Internal Medicine & Pediatrics

MEDICAL SCHOOL:
          •  University of South Florida - MD

  • Dalia S, Chavez J, Little B, Bello C, Fisher K, Lee JH, Chervenick P, Sokol L, Sotomayor E, Shah B. Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era. Ann Hematol. 2014 Aug;93(8):1305-1312. Pubmedid: 24590536.

  • Dalia S, Forsyth P, Chavez J, Price S, Shah B, Bello C, Sokol L, Pan E, Sotomayor E, Lee JH, Fisher K, Jaglal M. Primary B-cell CNS lymphoma clinicopathologic and treatment outcomes in 89 patients from a single tertiary care center. Int J Hematol. 2014 Apr;99(4):450-456. Pubmedid: 24584873.

  • Lwin T, Zhao X, Cheng F, Zhang X, Huang A, Shah B, Zhang Y, Moscinski LC, Choi YS, Kozikowski AP, Bradner JE, Dalton WS, Sotomayor E, Tao J. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas. J Clin Invest. 2013 Nov;123(11):4612-4626. Pubmedid: 24216476. Pmcid: PMC3809771.

  • Beltran BE, Qui?ones P, Morales D, Alva JC, Miranda RN, Lu G, Shah BD, Sotomayor EM, Castillo JJ. Follicular lymphoma with leukemic phase at diagnosis: a series of seven cases and review of the literature. Leuk Res. 2013 Sep;37(9):1116-1119. Pubmedid: 23790442. Pmcid: PMC4038155.

  • Martin P, Shah B. Limited-stage mantle cell lymphoma: not so different from advanced-stage. Leuk Lymphoma. 2013 Feb;54(2):217-218. Pubmedid: 22988842.

  • Cheng F, Wang H, Horna P, Wang Z, Shah B, Sahakian E, Woan KV, Villagra A, Pinilla-Ibarz J, Sebti S, Smith M, Tao J, Sotomayor EM. Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity. Cancer Res. 2012 Sep;72(17):4440-4448. Pubmedid: 22728650. Pmcid: PMC3990429.

  • Shah BD, Martin P, Sotomayor EM. Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches. Cancer Control. 2012 Jul;19(3):227-235. Pubmedid: 22710898. Pmcid: PMC4015063.

  • Holdener SL, Harrington L, Nguyen J, Horna P, Sagatys E, Shah B, Zhang L. Therapy-related B lymphoblastic leukemia with t(4;11)(q21;q23)/AF4-MLL in a patient with mantle cell lymphoma after recent aggressive chemotherapy - a unique case report. Int J Clin Exp Pathol. 2014 May;7(4):1800-1804. Pubmedid: 24817983.

  • Trimaldi J, Carballido EM, Bowers JW, Anguiano AL, Zhang ZJ, Shah BD, Bruno S, List AF, Moscinski LC, Grady T, Agosti SJ, Kang L, Zhang L. B-Lymphoblastic Leukemia/Lymphoma Associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : Rare Case and Review of the Literature. Acta Haematol. 2013 Apr;130(3):127-134. Pubmedid: 23594707.

  • Knapp KK, Shah B, Barnett MJ, Taylor TN, Miller L. Provider status and the need for additional qualified residency opportunities? response to Kudla. J Am Pharm Assoc (2003). 54(3):216-216. Pubmedid: 24728605.

Dr. Shah’s primary clinical interests are in non-Hodgkin lymphomas (particularly Mantle Cell Lymphoma) and acute leukemias (particularly acute lymphoblastic leukemia). As an internist and pediatrician, Dr. Shah also has a special interest in adolescent and young adult malignant hematology.

TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions